Join

Enter Details

Comment on stories, receive email newsletters & alerts.

@
This is your permanent identity for Business Insider Australia
Your email must be valid for account activation
Minimum of 8 standard keyboard characters

Subscribe

Email newsletters but will contain a brief summary of our top stories and news alerts.

Forgotten Password

Enter Details


Back to log in

Shares in medical cannabis company Creso Pharma are soaring

Robert GauthierLos Angeles Times via Getty Images

Creso Pharma shares jumped when the medical cannabis company debuted on the ASX.

The shares are up by a quarter since listing on Thursday at 25 cents. A short time ago, they were at 31.5 cents.

The company joined fellow medical marijuana companies, MGC Pharmaceuticals and Zelda Therapeutics, on the ASX on Thursday.

CEO Miri Halperin Wernli says many have rushed into the market with the re-discovery of the medical benefits of the cannabis plant.

“Our core difference is the level of methodological rigour we will bring to the sector that will complement traditional plant-derived cannabis treatments already on the market,” says Wernli.

The company raised $5 million in the listing, to be used to further develop Creso Pharma’s products treating anxiety, arthritis and pain.

The company is also looking at the vet market to treat pets.

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.